Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration.

Prieto-Potín I, Roman-Blas JA, Martínez-Calatrava MJ, Gómez R, Largo R, Herrero-Beaumont G.

Arthritis Res Ther. 2013 Aug 13;15(4):R81. doi: 10.1186/ar4261.

2.

RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.

Martínez-Calatrava MJ, Prieto-Potín I, Roman-Blas JA, Tardio L, Largo R, Herrero-Beaumont G.

Arthritis Res Ther. 2012 Jun 18;14(3):R149. doi: 10.1186/ar3884.

3.

[Alternatives in the treatment of rheumatoid arthritis: reasons for using abatacept].

Castañeda S, Martínez Calatrava MJ, Herrero-Beaumont G.

Rev Clin Esp. 2012 May;212(5):244-54. doi: 10.1016/j.rce.2011.09.008. Epub 2011 Dec 15. Review. Spanish.

PMID:
22176928
4.

Abatacept mechanism of action: concordance with its clinical profile.

Herrero-Beaumont G, Martínez Calatrava MJ, Castañeda S.

Reumatol Clin. 2012 Mar-Apr;8(2):78-83. doi: 10.1016/j.reuma.2011.08.002. Epub 2011 Nov 21. Review.

5.

Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits.

Romero FI, Martínez-Calatrava MJ, Sánchez-Pernaute O, Gualillo O, Largo R, Herrero-Beaumont G.

Br J Pharmacol. 2010 Nov;161(5):1012-22. doi: 10.1111/j.1476-5381.2010.00957.x.

6.

Chondroitin sulfate improves synovitis in rabbits with chronic antigen-induced arthritis.

Largo R, Roman-Blas JA, Moreno-Rubio J, Sánchez-Pernaute O, Martínez-Calatrava MJ, Castañeda S, Herrero-Beaumont G.

Osteoarthritis Cartilage. 2010 Jun;18 Suppl 1:S17-23. doi: 10.1016/j.joca.2010.01.017. Epub 2010 Apr 28.

7.

Improvement of experimental accelerated atherosclerosis by chondroitin sulphate.

Martínez-Calatrava MJ, Largo R, Herrero-Beaumont G.

Osteoarthritis Cartilage. 2010 Jun;18 Suppl 1:S12-6. doi: 10.1016/j.joca.2010.01.014. Epub 2010 Apr 24. Review.

8.

Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis.

Largo R, Martínez-Calatrava MJ, Sánchez-Pernaute O, Marcos ME, Moreno-Rubio J, Aparicio C, Egido J, Herrero-Beaumont G.

Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H268-76. doi: 10.1152/ajpheart.00142.2009. Epub 2009 May 1.

9.

Variant rs9939609 in the FTO gene is associated with obesity in an adult population from Spain.

González-Sánchez JL, Zabena C, Martínez-Larrad MT, Martínez-Calatrava MJ, Pérez-Barba M, Serrano-Ríos M.

Clin Endocrinol (Oxf). 2009 Mar;70(3):390-3. doi: 10.1111/j.1365-2265.2008.03335.x. Epub 2008 Jun 27.

PMID:
18616701
10.

Common haplotypes of the C-reactive protein gene and circulating leptin levels influence the interindividual variability in serum C-reactive protein levels. The Segovia study.

Martínez-Calatrava MJ, González-Sánchez JL, Martínez-Larrad MT, Pérez-Barba M, Serrano-Ríos M.

Thromb Haemost. 2007 Nov;98(5):1088-95.

PMID:
18000615
11.

Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.

González-Sánchez JL, Zabena C, Martínez-Larrad MT, Martínez-Calatrava MJ, Pérez-Barba M, Serrano-Ríos M.

Clin Endocrinol (Oxf). 2008 May;68(5):724-9. Epub 2007 Nov 6.

PMID:
17986276
12.

Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants.

Ramirez-Lorca R, Grilo A, Martinez-Larrad MT, Manzano L, Serrano-Hernando FJ, Moron FJ, Perez-Gonzalez V, Gonzalez-Sanchez JL, Fresneda J, Fernandez-Parrilla R, Moñux G, Molero E, Sanchez E, Martinez-Calatrava MJ, Saban-Ruiz J, Ruiz A, Saez ME, Serrano-Rios M.

Hypertension. 2007 Nov;50(5):884-90. Epub 2007 Sep 24.

13.

Is waist circumference an essential component of the metabolic syndrome?

Lorenzo C, Serrano-Ríos M, Martínez-Larrad MT, González-Villalpando C, González-Sánchez JL, Martínez-Calatrava MJ, Gabriel R, Haffner SM.

Diabetes Care. 2007 Aug;30(8):2141-2. Epub 2007 May 22. No abstract available.

PMID:
17519434
14.

Is the plasminogen activator inhibitor-1 gene a candidate gene predisposing to hypertension? Results from a population-based study in Spain.

Martínez-Calatrava MJ, González-Sánchez JL, Zabena C, Martínez-Larrad MT, Luque-Otero M, Serrano-Ríos M.

J Hypertens. 2007 Apr;25(4):773-7.

PMID:
17351368
15.

Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels.

Sáez ME, Martínez-Larrad MT, Ramírez-Lorca R, González-Sánchez JL, Zabena C, Martinez-Calatrava MJ, González A, Morón FJ, Ruiz A, Serrano-Ríos M.

BMC Med Genet. 2007 Jan 16;8:1.

16.

The 4G/4G PAI-1 genotype is associated with elevated plasma PAI-1 levels regardless of variables of the metabolic syndrome and smoking status. A population-based study in Spanish population.

Martínez-Calatrava MJ, Martínez-Larrad MT, Zabena C, González-Sánchez JL, Fernández-Pérez C, Serrano-Ríos M.

Diabetes Obes Metab. 2007 Jan;9(1):134-5.

PMID:
17199731
17.

Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome.

González-Sánchez JL, Martínez-Larrad MT, Sáez ME, Zabena C, Martínez-Calatrava MJ, Serrano-Ríos M.

Clin Chem. 2007 Jan;53(1):91-7. Epub 2006 Nov 16.

18.

Interaction of the -308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population.

González-Sánchez JL, Martínez-Calatrava MJ, Martínez-Larrad MT, Zabena C, Fernández-Pérez C, Laakso M, Serrano-Ríos M.

Clin Chem. 2006 Jan;52(1):97-103. Epub 2005 Oct 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk